{"result": "Here is a comprehensive summary of the data provided:\n\nTrastuzumab is a humanized anti-HER2 monoclonal antibody that is part of the anti-HER2 backbone for HER2+ IBC. It is a medication used in the treatment of HER2+ IBC, HER2-positive breast cancer, and breast cancer in general. Trastuzumab is a targeted therapy that targets HER2 receptors, blocking the HER2 protein to treat HER2-positive breast cancer. It is often used in combination with other medications, such as pertuzumab, docetaxel, and epirubicin, to treat breast cancer. Trastuzumab is also used in clinical trials and has been approved for HER2+ disease, including IBC. It is a type of monoclonal antibody that targets HER2 and is a treatment option for IBC, used in combination with lapatinib and paclitaxel. Additionally, trastuzumab is a chemotherapy drug used in the NeoSphere clinical trial and is a type of cancer treatment. Overall, trastuzumab is a medication used to treat HER2+ breast cancer by blocking the HER2 protein and is a targeted therapy approved for HER2+ disease, including IBC.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we the have full context.\n\n#######\n-Data-\nEntities: \"\\\"TRASTUZUMAB\\\"\"\nDescription List: [\"\", \"\\\"Trastuzumab is a humanized anti-HER2 monoclonal antibody that is part of the anti-HER2 backbone for HER2+ IBC.\\\"\", \"\\\"Trastuzumab is a medication used in breast cancer treatment.\\\"\", \"\\\"Trastuzumab is a medication used in cancer treatment.\\\"\", \"\\\"Trastuzumab is a medication used in the treatment of HER2+ IBC.\\\"\", \"\\\"Trastuzumab is a medication used in the treatment of HER2-positive breast cancer.\\\"\", \"\\\"Trastuzumab is a medication used in the treatment of breast cancer.\\\"\", \"\\\"Trastuzumab is a medication used to treat HER2+ breast cancer, especially in combination with pertuzumab.\\\"\", \"\\\"Trastuzumab is a medication used to treat HER2+ breast cancer.\\\"\", \"\\\"Trastuzumab is a medication used to treat HER2-positive breast cancer by blocking the HER2 protein.\\\"\", \"\\\"Trastuzumab is a targeted therapy approved for HER2+ disease, including IBC.\\\"\", \"\\\"Trastuzumab is a targeted therapy mentioned in the studies.\\\"\", \"\\\"Trastuzumab is a targeted therapy that targets HER2 receptors.\\\"\", \"\\\"Trastuzumab is a targeted therapy used to treat HER2-positive breast cancer.\\\"\", \"\\\"Trastuzumab is a technology used in combination with docetaxel and epirubicin in the treatment of breast cancer.\\\"\", \"\\\"Trastuzumab is a type of cancer treatment.\\\"\", \"\\\"Trastuzumab is a type of medication used in cancer treatment.\\\"\", \"\\\"trastuzumab is a HER2-targeting antibody.\\\"\", \"\\\"trastuzumab is a chemotherapy drug used in the NeoSphere clinical trial.\\\"\", \"\\\"trastuzumab is a chemotherapy drug.\\\"\", \"\\\"trastuzumab is a medication used in cancer treatment.\\\"\", \"\\\"trastuzumab is a monoclonal antibody that targets HER2.\\\"\", \"\\\"trastuzumab is a monoclonal antibody used in clinical trials.\\\"\", \"\\\"trastuzumab is a treatment option for IBC, used in combination with lapatinib and paclitaxel.\\\"\", \"\\\"trastuzumab is a treatment regimen for HER2+ breast cancer, often used in combination with pertuzumab.\\\"\", \"\\\"trastuzumab is a type of monoclonal antibody used to treat HER2+ breast cancer.\\\"\"]\n#######\nOutput:\n", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": null}}